Investing Profile
Matias Serebrinsky(304)
VCFounderOperator
Mental health and psychedelic therapeutics investor. Cofounder and GP at PsyMed Ventures.
psymed.venturesSan Francisco Bay Area
Your Intro Paths to Matias Serebrinsky
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Matias Serebrinsky's investing connections
14 Investors
Connected to Satya Patel (Homebrew), Aileen Lee (Cowboy Ventures), Morgan Beller (NFX), and 11 other investors on Signal.
Current Investing Position
PsyMed Ventures General Partner
Investment Range
$100K - $2.5M
Sweet Spot
$500K
Investments On Record
9
Matias Serebrinsky is on these Sector & Stage Rankings
Pharmaceuticals (Pre-seed)DeepTech (Pre-seed)Digital Health (Pre-seed)DeepTech (Series A)Pharmaceuticals (Series A)Pharmaceuticals (Seed)DeepTech (Seed)BioTech (Pre-seed)Health IT (Pre-seed)Digital Health (Series A)Digital Health (Seed)BioTech (Series A)BioTech (Seed)Health IT (Series A)Health IT (Seed)Investors who were foundersInvestors who invested in female foundersInvestors who invested in diverse foundersSan Francisco Bay Area
Matias Serebrinsky's Investments On Record (7)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Delix Therapeutics | Series ASep 2021$70M | $70M |
Mindstate | Seed+Sep 2021$250K | $250K |
Journey Clinical | SeedAug 2021$250K Pre-seedFeb 2021$150K | $12M |
Beckley Psytech | Series BJun 2021$1 | $80M £58M |
ATAI Life Sciences | Series DFeb 2021$3.6M Series COct 2020$130M | $650M |
Maya Health | SeedOct 2020$100K | $100K |
TRIPP | Series ASep 2017$4M | $26M |
most interested in
Investing in psychedelic medicine and tech that elevates health & wellness. Focus areas: -Psychedelics & New Compounds -Neurotech & BCI -Precision Psychiatry -Digital TherapeuticsMatias Serebrinsky's Experience
Head of Inception (startup ecosystem) NVIDIA2016 - 2021
Cofounder CookUnity2014 - 2016
Investors who invest with Matias Serebrinsky
Scouts & Angels Affiliated With Matias Serebrinsky